MedPath

Effectiveness of Group GDS and Individual GDS for Treatment of Low Back Pain in Primary Care

Not Applicable
Completed
Conditions
Subacute Nonspecific Low Back Pain
Chronic Nonspecific Low Back Pain
Registration Number
NCT01060280
Lead Sponsor
Kovacs Foundation
Brief Summary

A cluster, randomized, controlled clinical trial, where the hypothesis is that Group GDS and Individual GDS are effective in the treatment of nonspecific low back pain. The clusters will be the participating physiotherapy departments in primary care who treat patients with low back pain. In each physiotherapy department there will be 3 groups: education group, Group GDS and Individual GDS. Patients will be followed for 12 months. Variables will be: demographic,intensity of pain, disability, quality of life, patient satisfaction, medication intake for current episode, non-pharmacologic treatment for current episode, co-morbidity, diagnostic tests, sick leave, and habitual physical activity. The questionnaires to be used are: Roland Morris Disability Questionnaire, PI-NRS, VAS, SF-12 and EQ-5d.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
461
Inclusion Criteria
  • diagnosed with nonspecific low back pain by the primary care physician
  • more than or equal to 18 and less than or equal to 65 years of age
Exclusion Criteria
  • not signing the informed consent form
  • pregnancy
  • diagnosis of inflammatory rheumatologic disease, cancer, or fibromyalgia
  • signs for suspicion of fibromyalgia
  • having red flags for systemic disease
  • presenting criteria for urgent referral to surgery
  • presenting criteria for non-urgent referral to surgery
  • inability to read, understand, or follow verbal orders (dementia,blindness, doesn´t know how to read)
  • bedridden
  • having received physiotherapy in last 12 months

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Low back pain, referred pain and disabilityBaseline, 2, 6 and 12 months
Secondary Outcome Measures
NameTimeMethod
Self-reported health (PCS and MCS summaries of SF-12), and use of other pharmacologic and non-pharmacologic treatmentsBaseline, 2, 6 and 12 months

Trial Locations

Locations (1)

Areas Nº 1 and 11. Primary Care. Spanish National Health Service in Madrid (SERMAS)

🇪🇸

Madrid, Spain

Areas Nº 1 and 11. Primary Care. Spanish National Health Service in Madrid (SERMAS)
🇪🇸Madrid, Spain

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.